Maravai Lifesciences Holdings (MRVI) Tax Rate Growth (1y) (2021 - 2026)

Maravai Lifesciences Holdings (MRVI) Tax Rate Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,831.58 Bn 66,831.30 Bn -
2 Nanobiotix 1,916.61 Bn 1,916.55 Bn -
3 Akari Therapeutics 976.78 Bn 976.78 Bn -
4 BeOne Medicines 471.48 Bn 466.69 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.78 Bn 114.53 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.87 Bn 61.12 Bn 3.31 Bn
7 Belite Bio 63.06 Bn 63.06 Bn -
8 Argenx Se 55.78 Bn 50.60 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.54 Bn 34.53 Bn 959.66 Mn
10 Maravai Lifesciences Holdings 977.39 Mn 811.47 Mn 33.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 262.00
Dec 31, 2025 -2.00
Sep 30, 2025 38.00
Jun 30, 2025 -589.00
Mar 31, 2025 90.00
Dec 31, 2024 -11,675.00
Sep 30, 2024 -2,674.00
Jun 30, 2024 104.00
Mar 31, 2024 -7,141.00
Dec 31, 2023 10,795.00
Sep 30, 2023 1,415.00
Jun 30, 2023 19.00
Mar 31, 2023 5,822.00
Dec 31, 2022 -334.00
Sep 30, 2022 -7.00
Jun 30, 2022 264.00
Mar 31, 2022 -340.00
Dec 31, 2021 966.00
Sep 30, 2021 1,341.00
Jun 30, 2021 12,080.00